ARMED: an Australian cohort retrospective observational study to understand motivations for switching and clinical outcomes of individuals switching to dolutegravir/lamivudine
Daniela Eassey, Jason J. Ong, Ken Koh, David Nolan et autres
BACKGROUND: Although clinical trials and real-world studies demonstrate the efficacy and tolerability of dolutegravir and lamivudine (DTG + 3TC), Australian real-world evidence remains limited despite differences in access to health care and prescribing context. Here, we present the motivations for switching to …
ca, au, es, us (code pays fourni par la source)
0 citations
Sexual Health